Sign in
CompletedNo phase

HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial

Key facts

Who runs it
CHU de Quebec-Universite Laval
Where
Brazil, Canada, France, and United Kingdom33 sites in 4 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
742 people enrolled
Started
31 Aug 2017
Ended
16 Feb 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Red Blood Cells Transfusion
Record updated
3 May 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Acute moderate to severe blunt TBI
  • Glasgow Coma Score [GCS] ≤ 12
  • Hb level ≤ 100 g/L

Who cannot take part

  • Patient has received transfusion after ICU admission
  • A decision to withold or withdraw life-sustaining therapies was made
  • Active life-threatening bleeding with hemorrhagic shock or requiring urgent surgical procedure
  • Contraindications or known objection to transfusions
  • Glasgow Coma Scale (GCS) of 3 with dilated fixed pupils
  • Patient is brain dead
  • No fixed address

This trial has no sites in United States.

It has sites in 4 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Most trauma deaths are related to traumatic brain injury (TBI). Although the management of patients has improved, mortality remains unacceptably high, and half of survivors of moderate and severe TBI are left with major functional impairment. Current management guidelines are based on limited evidence and practice is highly variable. Most acutely ill patients with TBI will develop anemia, which may decrease oxygen delivery to a fragile brain. While clinical practice is moving towards transfusing at low hemoglobin (Hb) levels, experts have expressed concerns regarding restrictive strategies, which may adversely affect clinical outcomes in TBI. Our primary objective is to evaluate the effect of red blood cell (RBC) transfusion thresholds on neurological functional outcome. We hypothesize that a liberal transfusion strategy improves outcomes compared to a restrictive strategy.

The 2 groups in the trial

  • Liberal Transfusion StrategyTreatment being tested

    Patients will receive red blood cells transfusion if Hb ≤ 100 g/L.

    Treatment: Red Blood Cells Transfusion

  • Restrictive Transfusion StrategyTreatment being tested

    Patients will receive red blood cells transfusion if Hb ≤ 70 g/L.

    Treatment: Red Blood Cells Transfusion

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
3 May 2024